David E. Moller

30.9k citations
158 papers · 26.3k · 6 hit papers · h-index 72

Impact in

Papers in

    • Peroxisome Proliferator-Activated Receptors 53
    • Metabolism, Diabetes, and Cancer 41
    • Protein Kinase Regulation and GTPase Signaling 10
    • Diabetes, Cardiovascular Risks, and Lipoproteins 15
    • Diabetes Treatment and Management 14

David E. Moller

156 papers receiving 25.2k citations

David E. Moller's Hit Papers

The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes 2013 · 792 citations
7920+8+17Years since publication1k2k3k4k

Peers

David E. Moller
Comparison fields: 5 of 136
  • Endocrinology, Diabetes and Metabolism 4.4k
  • Molecular Biology 12.5k
  • Epidemiology 3.3k
  • Aging 170
  • Biochemistry 524
Replace David Ernest James with:
David Ernest James Australia
Michael Czech United States
Michael F. Hirshman United States
Kazuyuki Tobe Japan
Edward W. Kraegen Australia
Ira D. Goldfine United States
Lawrence J. Mandarino United States
Marc Foretz France
Jason K. Kim United States
Laurie J. Goodyear United States
David E. Moller relative to David Ernest James Australia David Ernest James's profile →
Citations per field
00.5×1.5×
David Ernest James · 1×
Citations per year

Countries citing papers authored by David E. Moller

Since Specialization
Citations

This map shows the geographic impact of David E. Moller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Moller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Moller more than expected).

Fields of papers citing papers by David E. Moller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Moller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Moller. The network helps show where David E. Moller may publish in the future.

Co-authors

The 25 scholars most cited alongside David E. Moller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Moller Line = papers co-authored together David E. Moller links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 158 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Role of AMP-activated protein kinase in mechanism of metformin action
Hit paper breakdown →
20014820
2
The Mechanisms of Action of PPARs
Hit paper breakdown →
20022260
3
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Hit paper breakdown →
2008933
4
New drug targets for type 2 diabetes and the metabolic syndrome
Hit paper breakdown →
2001898
5
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Hit paper breakdown →
2013792
6 2002702
7
Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Hit paper breakdown →
2000607
8 1996573
9 2004523
10 2002512
11 2006396
12 1999388
13 1999368
14 1996345
15 2003308
16 1993295
17 1990294
18 1996294
19 2003285
20 2000279

About David E. Moller

David E. Moller is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Epidemiology, Genetics and Biochemistry, having authored 158 papers that have together received 26.3k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (53 papers), Metabolism, Diabetes, and Cancer (41 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Diabetes Treatment and Management (14 papers), Protein Kinase Regulation and GTPase Signaling (10 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers), Pancreatic function and diabetes (8 papers) and Genetic Associations and Epidemiology (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.4k citations), Molecular Biology (12.5k citations), Epidemiology (3.3k citations), Aging (170 citations) and Biochemistry (524 citations). David E. Moller has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Joel P. Berger, Gaochao Zhou, Thomas W. Doebber, Jeffrey S. Flier, Laurie J. Goodyear, Margaret S. Wu, John R. Ventre, Michael F. Hirshman, Nicolas Musi and Judy E Fenyk-Melody. Their work appears in journals such as Journal of Biological Chemistry, Diabetes, Endocrinology, Bioorganic & Medicinal Chemistry Letters and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact